Teva recalls Ranitidine medicines batches in UK ▫️Earlier this month, MHRA reported that GlaxoSmithKline (GSK) issued a recall of all unexpired stock of four types of Zantac, which contains ranitidine as the active substance, due to contamination concerns. - Regulatory authorities, including the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA), are reviewing the potential contamination of ranitidine products. ▫️The Medicines and Healthcare products Regulatory Agency (MHRA) in the #UK has announced that Teva’s subsidiary is recalling batches of Ranitidine medicines. - Ranitidine is indicated to treat ailments such as heartburn and stomach ulcers. ▫️Teva UK recalled unexpired stock of 150µg and 300mg Ranitidine Effervescent Tablets over concerns of potential contamination with the N-nitrosodimethylamine (NDMA) impurity, linked to some cancers.
